Addressing the expected survival benefit for clinical trial design in metastatic castration-resistant prostate cancer: Sensitivity analysis of randomized trials.
about
Addressing the expected survival benefit for clinical trial design in metastatic castration-resistant prostate cancer: Sensitivity analysis of randomized trials.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Addressing the expected surviv ...... analysis of randomized trials.
@en
type
label
Addressing the expected surviv ...... analysis of randomized trials.
@en
prefLabel
Addressing the expected surviv ...... analysis of randomized trials.
@en
P2093
P50
P1476
Addressing the expected surviv ...... analysis of randomized trials.
@en
P2093
Alessandra Modena
Camillo Porta
Chiara Ciccarese
Francesca Maines
Francesco Massari
Giampaolo Tortora
Paolo Carlini
Sergio Bracarda
P304
P356
10.1016/J.CRITREVONC.2015.11.009
P577
2015-11-17T00:00:00Z